• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Dexcom has a Class I CGM receiver recall

June 17, 2025 By Sean Whooley

Dexcom One+ CGM phone and receiver (1)
The One+ offering with the sensor, app and receiver. [Image courtesy of Dexcom]
The FDA’s recall database today posted notices related to a Class I recall for continuous glucose monitor (CGM) components made by Dexcom (Nasdaq:DXCM).

Dexcom’s recalls relate to its Dexcom One and One+ offerings and the G6 and G7 CGMs. The One and One+ systems, which are mainly the company’s commercial CGM offering outside the U.S., feature the established G6 and G7 sensors along with other components such as an applicator and receiver.

According to the FDA, Dexcom’s recall came as a result of a potential issue with the receiver component. The reason centered around defective foam or an assembly error that may cause the receiver speaker to lose contact with the printed circuit board. FDA classified the cause as a “nonconforming material/component.”

Dexcom says the issue may lead to missed audible alerts for low or high blood glucose values. Missed alerts can lead to untreated hypoglycemia or hyperglycemia, which can lead to seizures, vomiting, loss of consciousness or death.

The company issued an urgent medical device correction notice on May 12. It then issued an update with actions for consignees to take. It instructed customers to contact the company’s technical support if they have an affected receiver to coordinate a return for the affected device and a no-charge replacement. Regardless of whether the device is affected, Dexcom recommends regular testing of the speaker function.

Units potentially impacted by the issue amount to 703,687, according to the FDA. (This article previously listed the total number of affected products at around 2 million. The FDA updated its recall listing to reflect that the number has decreased.)

Dexcom statement

A spokesperson issued the following statement on behalf of Dexcom:

In rare circumstances, certain Dexcom CGM receivers may experience issues with audio alerts and alarms due to the speaker not functioning as intended. This recall does not impact users who use Dexcom mobile apps as the display device for their glucose values, alerts and alarms, which constitutes a majority of our users globally. For the affected receivers which have been distributed, the reported incidence rate is 0.015%.

We are actively working with local regulatory agencies, and on May 12 began notifying users that may be impacted to check if their device is affected. If the user has an affected device, Dexcom will provide a no-cost replacement. Customers can check if their receiver is impacted at https://www.dexcom.com/checkreceiver.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Recalls, Regulatory/Compliance, Technology Tagged With: Dexcom, FDA

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS